Clinical research reliable commercial drug sourcing right now: We’re a specialist pharmaceutical supply company meeting global client requirements for clinical development. ClientPharma offers innovative sourcing and supply solutions from pre-clinical through to Phases I, II and III. Throughout the lifecycle of your drug development, it is our strategic approach that provides effective, tailored solutions that streamline the many complexities, avoiding supply chain disruptions and costly delays. See extra details at global clinical trial supply services and solutions.
True commitment to patient safety: ClientPharma is also committed to proactively driving quality — not only because it’s the foundation from which the pharmaceutical industry has been built, but we also understand the significance of the patients’ safety and well-being. It’s our professional duty to service our clients’ needs with the utmost attention and care. CP also has a personal stake in supporting the development of future medicines that will treat and help eliminate life threatening diseases, ensuring we enhance our lives and those of our loved ones.
Unbeatable global access to commercial drug products – Unlike many comparator drug sourcing companies, our ethos is to challenge the norms and adapt to your specific needs. We understand the complexities and challenges of multi-faceted projects with time and temperature specifics. Using a combined understanding of your clinical requisites and our extensive knowledge of the commercial market landscape, we work to design a supply strategy unique to your needs. Ask our team for a customized product supply assessment.
ClientPharma is proud to be the new sponsor of the Stretton Starlings netball team, continuing our goal to support equality in sports. As a result, we wish to showcase the team’s smart new match uniforms for the upcoming season, which sets a new precedent as an innovative way forward with the team wearing t-shirts rather than the ‘status quo’ netball dresses. After forming the team six months ago, the Starlings have just completed their first season collectively in a competitive netball league for the first time, emphasizing that age is no barrier with a range from 14 to 47 years old. The team has high expectations for the upcoming season and wishes to inspire, grow, develop, and celebrate local talent in welcoming ladies of all ages and abilities to come and join the team! Stretton Starlings are eager, driven and determined to commence the second season of the Leagues4you Burton-Upon-Trent Netball League, starting from the 9th of January 2023. Read extra info at https://www.clientpharma.com/.
Andrea Chopek, President, North America at ClientPharma relayed, “Our industry is yearning for a sleek, global approach for commercial drug supply — and with this strategic partnership, we offer that. Together, we solve drug supply difficulties and navigate the many complexities — reducing supply chain risks and managing waste and costs throughout the stages of your clinical trial. Two industry leaders coming together doesn’t dilute the solution, it provides one concentrated, easy solution for our clients.” TrialCard Incorporated is a full-service life sciences commercialization partner that provides comprehensive solutions that span the entire biopharmaceutical value chain. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. Founded in 2000, TrialCard provides commercialization needs for more than 160 life science customers and has connected over 35 million patients with more than $18 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.
Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on. In a survey of pharmaceutical Senior Managers it was reported that the majority of pharmaceutical companies had miscalculated demand for new medicines by up to 25%. Michael Lehmann, executive vice president of sales and marketing for Patheon, a global provider of outsourced pharmaceutical development and manufacturing said, “Making accurate demand forecasts is extremely challenging for pharmaceutical companies”.